Skip to main content
Clinical Trials/NCT03825276
NCT03825276UnknownNot Applicable

Metabolic Adaptations and Role of Nutritionally-Mediated Gut Microbiota Changes Following Mango Consumption in Overweight Men and Women : The MANGO Pilot Study

Laval University1 site in 1 country35 target enrollmentStarted: January 15, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
35
Locations
1
Primary Endpoint
Changes in plasma glucose concentration of overweight/obese men and women taking frozen mangos daily

Study Overview

Brief Summary

Mango is rich in bioactive compounds such as dietary polyphenols and carotenoids, which may explain its beneficial effect on health. Polyphenols accumulate in the gut where they can positively modulate the microbiota. As gut microbiota may have a strong influence on cardiometabolic health, we hypothesize that mango consumption improves metabolic profile in overweight or obese individuals through beneficial changes in gut microbiota. The study of metagenomics, transcriptomics and metabolomics will be used to validate this hypothesis.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy men and premenopausal women
  • •At least one of the following : BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men
  • •At least one of the following : TG ≥ 1.35 mmol/L or fasting insulinemia ≥ 42 pmol/L
  • •Caucasian origin

Exclusion Criteria

  • •Nicotine use
  • •Metabolic disorders or use of medication that may affect parameters measured in the study
  • •Use of dietary supplements or natural health product that may affect parameters measured in the study
  • •Use of antibiotics in the last 3 months
  • •Surgery in the last 3 months or planned during the study timeline
  • •Alcohol consumption >2 drinks/day
  • •Weight change >5% in the last 3 months
  • •Mango aversion, allergy or intolerance
  • •Dietary restrictions (vegetarian, gluten avoidance...)
  • •Berries consumption >1 serving/day
  • •Pregnancy, breastfeeding or pregnancy planned within 3-6 months

Arms & Interventions

Mango consumption

Experimental

Intervention: Mango consumption (Dietary Supplement)

Outcomes

Primary Outcomes

Changes in plasma glucose concentration of overweight/obese men and women taking frozen mangos daily

Time Frame: 8 weeks

Changes in plasma triglycerides concentration of overweight/obese men and women taking frozen mangos daily

Time Frame: 8 weeks

Changes in plasma HDL cholesterol concentration of overweight/obese men and women taking frozen mangos daily

Time Frame: 8 weeks

Changes in plasma insulin concentration of overweight/obese men and women taking frozen mangos daily

Time Frame: 8 weeks

Changes in plasma total cholesterol concentration of overweight/obese men and women taking frozen mangos daily

Time Frame: 8 weeks

Changes in plasma LDL cholesterol concentration of overweight/obese men and women taking frozen mangos daily

Time Frame: 8 weeks

Secondary Outcomes

  • Changes in weight of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in insulin sensitivity of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in glycated hemoglobin (HbA1c) in overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in waist to hip circumference ratio of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in diastolic blood pressure of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in plasma lipopolysaccharide (LPS) concentration of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in waist circumference of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Height of overweight/obese men and women taking frozen mangos daily(Baseline)
  • Changes in body mass index (BMI) of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in systolic blood pressure of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in insulin secretion of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in plasma interleukin-6 (IL-6) concentration of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in hip circumference of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in plasma high-sensitivity C-reactive protein (hs-CRP) concentration of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in gene expression in peripheral blood mononuclear cells (PBMC) of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in plasma metabolites concentration in overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in gut microbiota composition in overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in plasma tumor necrosis factor (TNF-alpha) concentration of overweight/obese men and women taking frozen mangos daily(8 weeks)
  • Changes in plasma LPS binding protein (LBP) concentration of overweight/obese men and women taking frozen mangos daily(8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Charles Couillard

Professor

Laval University

Study Sites (1)

Loading locations...

Similar Trials